Xin Wang is a Psychiatry physician. ClinicalTrials.gov lists 153 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11401 South Bloomfield Avenue
Norwalk, CA 90650
Telephone
562-863-7011Registry record last updated 8 Jul 2007.
Clinical trials
- Oliceridine Versus Sufentanil Analgesia for Postoperative Patients With Obstructive Sleep Apnea
Sponsor: Peking University First Hospital
- Dexmedetomidine-Esketamine Combination on Depression and Anxiety After Laparoscopic Ureteral Reconstruction
Sponsor: Peking University First Hospital
- Perioperative Transcranial Photobiomodulation and Delayed Neurocognitive Recovery in Older Patients
Sponsor: Peking University First Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ITI, Inc.Program year20222 payments
- Janssen Pharmaceuticals, IncProgram year20221 payment
- Janssen Pharmaceuticals, IncProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
80.1%Atypical Antipsychotic27.1%Quetiapine Fumarate63%Olanzapine20%Risperidone6%Aripiprazole5%Lurasidone Hcl4%Ziprasidone Hcl3%Part D<11 patientsSNRI10.8%Venlafaxine Hcl Er84%Duloxetine Hcl16%Part D<11 patients+ 12 more classes in this area
Cardiovascular
7.8%Statin2.2%Atorvastatin Calcium100%Part D<11 patientsBeta blocker2%Metoprolol Tartrate66%Timolol Maleate34%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
3.1%H2 blocker1.6%Famotidine100%Part D<11 patientsInsulin0.9%Novolin R100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2008–2025 per NIH RePORTER. The latest:
- Spatial Regulators of Skeletal Muscle Regeneration and Disease
Sanford Burnham Prebys Medical Discovery Institute
FY2025$248,721R00NS120278 - Spatial Regulators of Skeletal Muscle Regeneration and Disease
Sanford Burnham Prebys Medical Discovery Institute
FY2024$241,260R00NS120278 - Spatial Regulators of Skeletal Muscle Regeneration and Disease
Sanford Burnham Prebys Medical Discovery Institute
FY2023$248,721R00NS120278
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”